MENU

PubMed

PubMed

Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Edition: 1048-891X | Pages: 104500
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/SHAPE trial.
Gynecologic oncology
Edition: 0090-8258 | Pages: 37-45
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer.
Maturitas
Edition: 0378-5122 | Pages: 108805

Citations

1
Ex vivo 3D micro-tumour testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.
NPJ precision oncology
Edition: 2397-768X | Pages: 306

Citations

2
Surgical approach, preoperative LEEP/conization and patterns of recurrence and death in low-risk cervical cancer - exploratory analysis from the CCTG CX.5/SHAPE trial.
International journal of surgery (London, England)
Edition: 1743-9191 | Pages: 8099-8107
Granulosa cell tumor patients presenting with acute abdomen: a case series.
Gynecologic oncology reports
Edition: 2352-5789 | Pages: 101781

Citations

2
The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients.
Cancers
Edition: 2072-6694 | Pages: 1894
Leveraging real-world data for continuous evaluation of computational clinical practice guidelines.
BMJ health & care informatics
Edition: 2632-1009 | Pages: e101333
Development of a surgical competency assessment tool for sentinel lymph node dissection by minimally invasive surgery for endometrial cancer.
Studies in health technology and informatics
Edition: 0926-9630 | Pages: 1393-1397

Citations

2
Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancer.
Gynecologic oncology
Edition: 0090-8258 | Pages: 43-50